iBio, Inc. raised $15.0 million in a private placement financing led by ADAR1 Capital Management, Lynx1 Capital Management, and Ikarian Capital to fund research and development of precision antibody immunotherapies.
Amount Raised
$15 Million
Round Type
Post-IPO Equity
New YorkManufacturingBiotechnologyInvestors
Description
iBio, Inc. announced a private investment in public equity (PIPE) financing of approximately $15.0 million. The financing included participation from ADAR1 Capital Management, Lynx1 Capital Management, Ikarian Capital, and other institutional and accredited investors. The net proceeds will be used for general corporate purposes, including research and development and working capital, extending its cash runway through fiscal year 2025.
Quick answer
iBio raised $15 Million in a Post-IPO Equity round, dated March 28, 2024. Investors: Ikarian Capital, Lynx1 Capital Management and Adar1 Capital Management. iBio is based in New York, New York, United States.
- How much did iBio raise?
- iBio raised $15 Million in a Post-IPO Equity round on March 28, 2024.
- Who invested in iBio?
- Ikarian Capital, Lynx1 Capital Management and Adar1 Capital Management are named as investors in this round.
- What does iBio do?
- iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases.
- Where is iBio based and how big is it?
- iBio is based in New York, New York, United States. Fundz records about 16 employees.
- Who are the decision-makers at iBio?
- Fundz holds 2 contacts at iBio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at iBio, and when
A new round usually means iBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
iBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.